TCRT

Quote

Short

News

Articles

Message Board

Alaunos Therapeutics Inc. (NASDAQ : TCRT ) News

News Releases

TCRT News Releases

June 29, 2026 08:35:00 am

GlobeNewswire

Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study

May 26, 2026 11:01:00 am

GlobeNewswire

Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies

May 18, 2026 08:00:00 am

GlobeNewswire

Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models

May 04, 2026 04:05:00 pm

PR Newswire

Valion Bio Appoints Melinda Lackey as General Counsel

March 02, 2026 06:30:57 am

GlobeNewswire

Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders

August 13, 2025 07:00:57 am

US Earnings Reports

Expected US Company Earnings on Wednesday, August 13th, 2025

August 13, 2025 05:31:25 am

US Earnings Reports

Expected earnings - Alaunos Therapeutics Inc.

June 23, 2025 08:45:06 am

SeekingAlpha

Alaunos Therapeutics stock slides on $2M equity offering

June 23, 2025 08:00:00 am

GlobeNewswire

Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering

June 18, 2025 09:52:27 am

GlobeNewswire

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account